Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Baxter International Inc (BAX)

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,083,752
  • Shares Outstanding, K 510,556
  • Annual Sales, $ 11,127 M
  • Annual Income, $ 1,624 M
  • 60-Month Beta 0.97
  • Price/Sales 3.58
  • Price/Cash Flow 16.93
  • Price/Book 5.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.85
  • Number of Estimates 9
  • High Estimate 0.88
  • Low Estimate 0.83
  • Prior Year 0.80
  • Growth Rate Est. (year over year) +6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.67 +4.49%
on 10/25/19
89.10 -11.26%
on 10/21/19
-8.96 (-10.18%)
since 10/11/19
3-Month
75.67 +4.49%
on 10/25/19
89.93 -12.08%
on 09/06/19
-6.90 (-8.03%)
since 08/09/19
52-Week
61.40 +28.78%
on 12/24/18
89.93 -12.08%
on 09/06/19
+15.59 (+24.56%)
since 11/09/18

Most Recent Stories

More News
Global Kidney Dialysis Equipment Market to Surpass US$ 29.9 Billion by 2027 - Coherent Market Insights

According to Coherent Market Insights, the global kidney dialysis equipment market was valued at US$ 16,874.5 million in 2018, and is expected to exhibit a CAGR of 6.6% over the forecast period (2019-2027)....

BAX : 79.18 (+0.85%)
SHAREHOLDER ALERT: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Baxter International Inc. - BAX

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), is investigating claims on behalf of investors of Baxter International Inc....

BAX : 79.18 (+0.85%)
Baxter to Present at the Evercore ISI 2nd Annual HealthCONx Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019. Jay Saccaro, Baxter's chief...

BAX : 79.18 (+0.85%)
EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Baxter International Inc.

Levi & Korsinsky reminds investors that it has commenced an investigation of Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX) concerning possible violations of federal securities laws....

BAX : 79.18 (+0.85%)
Bragar Eagel & Squire, P.C. Is Investigating Merit Medical Systems, Baxter International, Under Armour, and BeiGene on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against Merit Medical Systems, Inc. (NASDAQ: MMSI), Baxter International, Inc. (NYSE: BAX),...

UA : 15.82 (-0.38%)
UAA : 17.53 (-0.17%)
MMSI : 25.57 (-4.16%)
BAX : 79.18 (+0.85%)
BGNE : 192.80 (-3.33%)
Baxter and Ayogo Launch CKD&Me Patient Empowering Digital Education Tool at Kidney Week 2019

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Ayogo Health Inc., a behavioral science, digital health company, today announced the pilot of CKD&Me in several nephrology practices...

BAX : 79.18 (+0.85%)
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation on Behalf of Baxter International Inc. Investors

Law Offices of Howard G. Smith continues its investigation on behalf of Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) investors concerning the Company and its officers' possible violations...

BAX : 79.18 (+0.85%)
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Baxter International (BAX) Investors with $50K Plus Losses to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud

Hagens Berman reminds Baxter International (NYSE: BAX) investors of the firm's investigation of possible violations of federal securities laws. The firm urges Baxter International investors who have suffered...

BAX : 79.18 (+0.85%)
Nasal Drug Delivery Systems Market M&A Activity, SWOT Analysis, Financials Overiew, Key Developments by 2026

In 2018, the Nasal Drug Delivery Systems Market revenue was around US$ XX Mn and the Market share was XX%, and it will be projected to reach US$ XX Mn and XX% in 2026, with a CAGR XX% during the forecast...

BAX : 79.18 (+0.85%)
MRK : 83.12 (-0.56%)
NVS : 88.72 (+0.40%)
VRX.TO : 30.80 (-3.33%)
ROSEN, A HIGHLY RANKED LAW FIRM, Continues Its Investigation of Securities Claims Against Baxter International Inc. - BAX

Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX), resulting from allegations that...

BAX : 79.18 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade BAX with:

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare...

See More

Key Turning Points

2nd Resistance Point 79.28
1st Resistance Point 78.89
Last Price 79.18
1st Support Level 77.90
2nd Support Level 77.30

See More

52-Week High 89.93
Last Price 79.18
Fibonacci 61.8% 79.03
Fibonacci 50% 75.67
Fibonacci 38.2% 72.30
52-Week Low 61.40

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar